PMC:3724992 / 1957-2432 JSONTXT

Annnotations TAB JSON ListView MergeView

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/3724992","sourcedb":"PMC","sourceid":"3724992","source_url":"https://www.ncbi.nlm.nih.gov/pmc/3724992","text":"Anti-tumor vaccination is based on the existence of antigens, selectively or preferentially expressed by tumors, called tumor-associated antigens (TAAs) [12–14]. Vaccination with peptides derived from TAAs designed to stimulate specific T-cells is being a practicable approach evaluated in clinical trials [15–17]. To investigate the immune response elicited by neuritin CTL epitopes, the present study was undertaken to identify candidate CTL epitopes derived from neuritin.","tracks":[{"project":"2_test","denotations":[{"id":"23754640-18438665-63236737","span":{"begin":154,"end":156},"obj":"18438665"},{"id":"23754640-16530303-63236737","span":{"begin":154,"end":156},"obj":"16530303"},{"id":"23754640-18302222-63236737","span":{"begin":154,"end":156},"obj":"18302222"},{"id":"23754640-19545862-63236738","span":{"begin":307,"end":309},"obj":"19545862"},{"id":"23754640-19505380-63236738","span":{"begin":307,"end":309},"obj":"19505380"},{"id":"23754640-19445013-63236738","span":{"begin":307,"end":309},"obj":"19445013"}],"attributes":[{"subj":"23754640-18438665-63236737","pred":"source","obj":"2_test"},{"subj":"23754640-16530303-63236737","pred":"source","obj":"2_test"},{"subj":"23754640-18302222-63236737","pred":"source","obj":"2_test"},{"subj":"23754640-19545862-63236738","pred":"source","obj":"2_test"},{"subj":"23754640-19505380-63236738","pred":"source","obj":"2_test"},{"subj":"23754640-19445013-63236738","pred":"source","obj":"2_test"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"2_test","color":"#93c8ec","default":true}]}]}}